Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

2 structures for Q8BUR4

Entry ID Method Resolution Chain Position Source
2M0Y NMR - A 1-74 PDB
AF-Q8BUR4-F1 Predicted AlphaFoldDB

86 variants for Q8BUR4

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3388957616 69 E>A No EVA
rs3388950849 140 D>N No EVA
rs3388957636 154 D>Y No EVA
rs3413117473 182 I>S No EVA
rs3388957588 213 R>I No EVA
rs3388950816 228 N>Y No EVA
rs3388948785 242 V>I No EVA
rs3388954080 250 M>L No EVA
rs3388958950 263 W>C No EVA
rs3388957807 283 T>M No EVA
rs3398632811 293 E>K No EVA
rs3398600307 293 E>V No EVA
rs3388959018 297 F>L No EVA
rs3388953992 311 D>Y No EVA
rs3388957635 409 V>M No EVA
rs3388958960 446 K>M No EVA
rs3388957631 482 I>V No EVA
rs3388928022 483 Y>* No EVA
rs3388910649 499 I>T No EVA
rs3388955303 574 K>E No EVA
rs3388961196 575 G>R No EVA
rs3388938160 589 M>L No EVA
rs3388938160 589 M>V No EVA
rs3388955264 602 F>I No EVA
rs3388961186 610 S>T No EVA
rs3388957182 646 E>D No EVA
rs3388958944 653 D>E No EVA
rs3388954259 665 N>S No EVA
rs3388959064 671 F>S No EVA
rs3388938161 684 G>R No EVA
rs3388948778 718 V>M No EVA
rs249461931 729 P>L No EVA
rs3388944833 787 S>T No EVA
rs3412481391 804 I>V No EVA
rs3398811897 807 D>V No EVA
rs3388959057 819 K>* No EVA
rs3388953990 837 K>M No EVA
rs3388959126 859 L>Q No EVA
rs3388950850 860 L>P No EVA
rs3388938239 884 L>F No EVA
rs3398683163 889 E>V* No EVA
rs3388910593 896 V>A No EVA
rs3388954033 927 L>R No EVA
rs3388910595 928 I>F No EVA
rs225879222 994 K>R No EVA
rs3388955288 1001 N>K No EVA
rs3388959037 1002 Q>H No EVA
rs3388928043 1034 T>S No EVA
rs3388957602 1042 N>K No EVA
rs3388928011 1153 L>P No EVA
rs3388957638 1157 C>S No EVA
rs3388961181 1191 E>* No EVA
rs3388961224 1203 V>E No EVA
rs3388953986 1203 V>M No EVA
rs3388950291 1220 L>S No EVA
rs3388957831 1233 Y>N No EVA
rs3388934731 1273 K>* No EVA
rs3388957849 1277 Y>N No EVA
rs3388950838 1280 I>F No EVA
rs3388960363 1335 K>N No EVA
rs3388951625 1338 Y>* No EVA
rs3388954216 1351 F>L No EVA
rs3388927981 1395 K>N No EVA
rs3388938226 1396 T>A No EVA
rs3388951597 1426 V>I No EVA
rs3388960303 1444 R>L No EVA
rs3388954022 1445 K>E No EVA
rs3388954223 1493 A>V No EVA
rs3388954079 1503 K>R No EVA
rs3398588227 1558 H>Q No EVA
rs3388959053 1603 Q>* No EVA
rs3398335113 1661 R>W No EVA
rs3388961249 1694 K>M No EVA
rs3388955300 1697 K>N No EVA
rs3388950240 1699 K>N No EVA
rs3388934714 1702 R>G No EVA
rs3388955315 1708 E>K No EVA
rs3398814224 1739 Q>H No EVA
rs249903678 1784 S>G No EVA
rs227864568 1807 N>I No EVA
rs227864568 1807 N>S No EVA
rs235966441 1815 M>I No EVA
rs3388938153 1831 P>H No EVA
rs3388961183 1836 Q>* No EVA
rs3388957764 1849 P>L No EVA
rs3388934665 1860 D>E No EVA

No associated diseases with Q8BUR4

9 regional properties for Q8BUR4

Type Name Position InterPro Accession
domain SH3 domain 9 - 70 IPR001452
domain C2 DOCK-type domain 421 - 617 IPR027007
domain DOCKER domain 1207 - 1617 IPR027357
domain Dedicator of cytokinesis, N-terminal domain 73 - 416 IPR032376
domain DOCKER, Lobe A 1202 - 1330 IPR046769
domain DOCKER, Lobe B 1388 - 1469 IPR046770
domain DOCKER, Lobe C 1508 - 1610 IPR046773
domain Dedicator of cytokinesis protein 1/5, SH3 domain 13 - 68 IPR047025
domain Dedicator of cytokinesis protein 1, C2 domain 424 - 619 IPR047026

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
  • Membrane
  • Recruited to membranes via its interaction with phosphatidylinositol 3,4,5-trisphosphate
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

6 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
guanyl-nucleotide exchange factor complex A protein complex that stimulates the exchange of guanyl nucleotides associated with a GTPase.
nuclear speck A discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

3 GO annotations of molecular function

Name Definition
guanyl-nucleotide exchange factor activity Stimulates the exchange of GDP to GTP on a signaling GTPase, changing its conformation to its active form. Guanine nucleotide exchange factors (GEFs) act by stimulating the release of guanosine diphosphate (GDP) to allow binding of guanosine triphosphate (GTP), which is more abundant in the cell under normal cellular physiological conditions.
SH3 domain binding Binding to a SH3 domain (Src homology 3) of a protein, small protein modules containing approximately 50 amino acid residues found in a great variety of intracellular or membrane-associated proteins.
small GTPase binding Binding to a small monomeric GTPase.

8 GO annotations of biological process

Name Definition
apoptotic process A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
cell migration The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.
hematopoietic progenitor cell differentiation The process in which precursor cell type acquires the specialized features of a hematopoietic progenitor cell, a class of cell types including myeloid progenitor cells and lymphoid progenitor cells.
myoblast fusion A process in which non-proliferating myoblasts fuse to existing fibers or to myotubes to form new fibers. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
phagocytosis A vesicle-mediated transport process that results in the engulfment of external particulate material by phagocytes and their delivery to the lysosome. The particles are initially contained within phagocytic vacuoles (phagosomes), which then fuse with primary lysosomes to effect digestion of the particles.
positive regulation of epithelial cell migration Any process that activates or increases the frequency, rate or extent of epithelial cell migration.
positive regulation of substrate adhesion-dependent cell spreading Any process that activates or increases the frequency, rate or extent of substrate adhesion-dependent cell spreading.
small GTPase mediated signal transduction The series of molecular signals in which a small monomeric GTPase relays a signal.

5 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q92608 DOCK2 Dedicator of cytokinesis protein 2 Homo sapiens (Human) PR
Q9H7D0 DOCK5 Dedicator of cytokinesis protein 5 Homo sapiens (Human) PR
Q14185 DOCK1 Dedicator of cytokinesis protein 1 Homo sapiens (Human) PR
Q8C3J5 Dock2 Dedicator of cytokinesis protein 2 Mus musculus (Mouse) PR
Q8CIQ7 Dock3 Dedicator of cytokinesis protein 3 Mus musculus (Mouse) PR
10 20 30 40 50 60
MTRWVPTKRE EKYGVAFYNY DARGADELSL QIGDTVHILE TYEGWYRGYT LRKKSKKGIF
70 80 90 100 110 120
PASYIHLKEA IVEGKGQHET VIPGDLPLIQ EVTTTLREWS TIWRQLYVQD NREMFRSVRH
130 140 150 160 170 180
MIYDLIEWRS QILSGTLPQD ELKELKKKVT AKIDYGNRIL DLDLVVRDED GNILDPELTS
190 200 210 220 230 240
TISLFRAHEV ASKQVEERLQ EEKSQKQNMD INRQAKFAAT PSLALFVNLK NVVCKIGEDA
250 260 270 280 290 300
EVLMSLYDPM ESKFISENYL VRWSSSGLPK DIDRLHNLRA VFTDLGSKDL KREKISFVCQ
310 320 330 340 350 360
IVRVGRMELR DSNTRKLTSG LRRPFGVAVM DVTDIINGKV DDEDKQHFIP FQAVAGENDF
370 380 390 400 410 420
LQTVINKVIA AKEVNHKGQG LWVTLKLLPG DIHQIRKEFP HLVDRTTAVA RKTGFPEIIM
430 440 450 460 470 480
PGDVRNDIYV TLVQGDFDKG SKTTAKNVEV TVSVYDEDGK RLEHVIFPGA GDEAISEYKS
490 500 510 520 530 540
VIYYQVKQPR WFETLKVAIP IEDVNRSHLR FTFRHRSSQD SKDKSEKIFA LAFVKLMRYD
550 560 570 580 590 600
GTTLRDGEHD LIVYKAEAKK LEDAATYLSL PSTKGELEEK GHSATGKGMQ SLGSCTISKD
610 620 630 640 650 660
SFQISTLVCS TKLTQNVDLL GLLKWRSNTN LLQQNLRQLM KVDGGEVVKF LQDTLDALFN
670 680 690 700 710 720
IMMENSESET FDTLVFDALV FIIGLIADRK FQHFNPVLET YIKKHFSATL AYTKLTKVLR
730 740 750 760 770 780
TYVASAEKPG VNEQLYKAIK ALEYIFKFIV RSRVLFNQLY ENKGEADFVE SLLQLFRSIN
790 800 810 820 830 840
DMMSSLSELT VRVKGAALKY LPTIVNDVKL VFDPKELSKM FTEFILNVPA GLLTVQKLSC
850 860 870 880 890 900
LIEIVHSDLF TQHDCREILL PMMTDQLKYH LERQEELEAC CQLLSNILEV LYRKDVGPTQ
910 920 930 940 950 960
RHVQIIMETL LRTVNRTVIS MGRDSELIGN FVACMTAILR QMEDYHYAHL IKTFGKMRTD
970 980 990 1000 1010 1020
VVDFLMETFI MFKNLIGKNV YPFDWVIMNT MQNKVFLRAI NQYADMLNKR FLDQANFELQ
1030 1040 1050 1060 1070 1080
LWNNYFHLAV AFLTQESLQL ENFSSAKRAK ILNKYGDMRR QIGFEIRDMW YNLGQHKIKF
1090 1100 1110 1120 1130 1140
IPEMVGPILE MTLIPETELR KATLPIFFDM MQCEFHSTRS FQMFENEIIT KLDHEVEGGR
1150 1160 1170 1180 1190 1200
GDEQYKVLFD KILLEHCRKH KYLAKTGETF VKLVVRLMER LLDYRTIMHD ENKDNRMSCT
1210 1220 1230 1240 1250 1260
VNVLNFYKEI EREEMYIRYL YKLCDLHKEC DNYTEAAYTL LLHAKLLKWS EDVCAAHLTQ
1270 1280 1290 1300 1310 1320
RDGFQATTQG QLKEQLYQEI IHYFDKGKMW EEAIALGKEL AEQYETEMFD YEQLSELLKK
1330 1340 1350 1360 1370 1380
QAQFYENIVK VIRPKPDYFA VGYYGQGFPS FLRGKVFIYR GKEYERREDF EARLLTQFPN
1390 1400 1410 1420 1430 1440
AEKMKTTSPP GDDIKTSPGQ YIQCFTVKPK LDLPPRFHRP VSEQIVSFYR VNEVQRFEYS
1450 1460 1470 1480 1490 1500
RPIRKGEKNP DNEFANMWIE RTIYTTAYKL PGILRWFEVK SVFMVEISPL ENAIETMQLT
1510 1520 1530 1540 1550 1560
NDKISSMVQQ HLDDPGLPIN PLSMLLNGIV DPAVMGGFAN YEKAFFTDRY LQEHPEAHGQ
1570 1580 1590 1600 1610 1620
IEKLKDLIAW QIPFLAEGIR IHGDKVTEAL RPFHERMEAC FKQLKEKVEK QYGVRTMPSG
1630 1640 1650 1660 1670 1680
LDDRRGSRPR SMVRSFTMPS SSRPLSVASV SSFSSDSTPS RPGSDGFALE PLLPKKMHSR
1690 1700 1710 1720 1730 1740
SQDKLDKDDP DKEKKDKKKE KRNSKHQEIF DKEFKPADSS LQQSEAVILS ETISPLRPQR
1750 1760 1770 1780 1790 1800
PKSQVINVIG NERRFSVSPA SPSSQQTPPP VTPRAKLSFS IQPSLELNGM MGMDVADVPP
1810 1820 1830 1840 1850 1860
PLPLKGNMAD YGNLMENQDM MVSPTSPPPP PPQRQQPPPL PSKTPPPPPP KTTRKQTSVD
SGIVQ